dos Santos Almeida, Rodrigoa; Mamede, Marcelob; Santos-Oliveira, Ralpha,c the Brazilian Office of Pharmacovigilance of Radiopharmaceuticals
aBrazilian Office of Pharmacovigilance of Radiopharmaceuticals, Rio de Janeiro
bMolecular Imaging Center, Minas Gerais Federal University, Minas Gerais
cInstitute of Radiopharmacy, Zona Oeste Estadual University, Rio de Janeiro, Brazil
Correspondence to Dr Ralph Santos-Oliveira, Rua Hélio de Almeida 75, Ilha do Governador, Rio de Janeiro, Brazil. E-mail: [email protected]
Editor: R E Ferner, MSc, MD, FRCP, Director of the West Midlands Centre for Adverse Drug Reaction Reporting and Consultant Physician at City Hospital, Birmingham, UK. Assistant Editor: Mr C Anton, MA, MEng. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield, Denmark: Professor J S Schou; England: Dr J K Aronson; India: Professor N Gogtay; Netherlands: Professor C J van Boxtel, Dr B H Ch Stricker; New Zealand: Dr T Maling; Scotland: Dr D N Bateman; Wales: Professor P A Routledge.
